NHBA.F Stock Overview
Develops, manufactures, and sells medical products and tapes in Asia and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Nichiban Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥12.70 |
| 52 Week High | JP¥12.70 |
| 52 Week Low | JP¥12.70 |
| Beta | 0.52 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| NHBA.F | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | 0% | 0.05% | 1.8% |
| 1Y | n/a | 25.9% | 24.0% |
Return vs Industry: Insufficient data to determine how NHBA.F performed against the US Commercial Services industry.
Return vs Market: Insufficient data to determine how NHBA.F performed against the US Market.
Price Volatility
| NHBA.F volatility | |
|---|---|
| NHBA.F Average Weekly Movement | n/a |
| Commercial Services Industry Average Movement | 6.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NHBA.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NHBA.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1918 | 1,255 | Toshiaki Takatsu | www.nichiban.co.jp |
Nichiban Co., Ltd. manufactures and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, dressing tapes, first-aid bandages, hemostatic bandages, and others. The company also provides OTC products, such as anti-inflammatory patches, foot care products, waterproof films, and bandages.
Nichiban Co., Ltd. Fundamentals Summary
| NHBA.F fundamental statistics | |
|---|---|
| Market cap | US$245.56m |
| Earnings (TTM) | US$11.03m |
| Revenue (TTM) | US$315.47m |
22.3x
P/E Ratio0.8x
P/S RatioIs NHBA.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHBA.F income statement (TTM) | |
|---|---|
| Revenue | JP¥43.42b |
| Cost of Revenue | JP¥30.16b |
| Gross Profit | JP¥13.26b |
| Other Expenses | JP¥11.74b |
| Earnings | JP¥1.52b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 73.26 |
| Gross Margin | 30.54% |
| Net Profit Margin | 3.50% |
| Debt/Equity Ratio | 5.2% |
How did NHBA.F perform over the long term?
See historical performance and comparison